ETON PHARMACEUTICALS INC's ticker is ETON and the CUSIP is 29772L108. A total of 33 filers reported holding ETON PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $339,451 | +37.0% | 81,403 | +14.6% | 0.00% | – |
| Q2 2023 | $247,800 | -9.4% | 71,003 | 0.0% | 0.00% | – |
| Q1 2023 | $273,362 | -31.2% | 71,003 | -50.0% | 0.00% | – |
| Q4 2022 | $397,616 | +166.9% | 142,006 | +100.0% | 0.00% | – |
| Q3 2022 | $149,000 | -27.0% | 71,003 | -8.9% | 0.00% | – |
| Q2 2022 | $204,000 | -48.9% | 77,903 | -15.0% | 0.00% | – |
| Q1 2022 | $399,000 | +11.1% | 91,603 | +9.3% | 0.00% | – |
| Q4 2021 | $359,000 | -14.9% | 83,772 | 0.0% | 0.00% | – |
| Q3 2021 | $422,000 | -18.2% | 83,772 | 0.0% | 0.00% | – |
| Q2 2021 | $516,000 | -73.5% | 83,772 | -68.5% | 0.00% | – |
| Q1 2021 | $1,949,000 | -1.9% | 266,295 | +9.0% | 0.00% | – |
| Q4 2020 | $1,987,000 | +41.4% | 244,395 | +37.4% | 0.00% | – |
| Q3 2020 | $1,405,000 | +70.9% | 177,876 | +17.9% | 0.00% | – |
| Q2 2020 | $822,000 | – | 150,896 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,430,270 | $10,134,226 | 3.30% |
| Westside Investment Management, Inc. | 528,310 | $2,203,060 | 0.63% |
| Acuitas Investments, LLC | 219,000 | $913,230 | 0.54% |
| EAM Investors, LLC | 256,623 | $1,070,118 | 0.21% |
| Parkman Healthcare Partners LLC | 165,000 | $688,050 | 0.13% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 110,016 | $458,767 | 0.08% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 300,000 | $1,251,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 271,462 | $1,131,997 | 0.03% |
| Quantum Private Wealth, LLC | 11,500 | $47,955 | 0.02% |
| CHICAGO TRUST Co NA | 16,700 | $69,639 | 0.02% |